Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
VVOS on Nasdaq
Shares outstanding
6,713,803
Price per share
$2.06
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
686,727
Total reported value
$2,129,135
% of total 13F portfolios
0%
Share change
+282,280
Value change
+$875,076
Number of holders
22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
V-CO Investors LLC 20% +100% $4,188,594 +$2,583,360 1,342,498 +161% SP Manager LLC 09 Jun 2025
LUO DAWEI 8.5% $1,784,690 572,016 Dawei Luo 08 Jul 2025
INTRACOASTAL CAPITAL, LLC 5% $707,610 297,315 Mitchell P. Kopin 22 Dec 2024

As of 30 Sep 2025, 22 institutional investors reported holding 686,727 shares of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS). This represents 10% of the company’s total 6,713,803 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) together control 10% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Connective Capital Management, LLC 3% 200,000 0.57% $620,000
Strategic Wealth Investment Group, LLC 1.5% 100,000 0.03% $310,000
VANGUARD GROUP INC 1.4% 91,461 +115% 0% $283,529
GEODE CAPITAL MANAGEMENT, LLC 0.79% 53,289 -8% 0% $165,195
B. Riley Wealth Advisors, Inc. 0.65% 43,531 -37% 0.01% $134,946
DRW Securities, LLC 0.62% 41,466 0.01% $128,544
COMMONWEALTH EQUITY SERVICES, LLC 0.61% 41,000 0% 0% $127,000
RENAISSANCE TECHNOLOGIES LLC 0.59% 39,279 0% $121,765
BlackRock, Inc. 0.41% 27,817 0% $86,233
STATE STREET CORP 0.37% 24,922 +111% 0% $77,258
NORTHERN TRUST CORP 0.19% 12,511 0% 0% $38,784
OSAIC HOLDINGS, INC. 0.1% 6,553 +726% 0% $20,732
Tower Research Capital LLC (TRC) 0.04% 2,794 +462% 0% $8,661
MORGAN STANLEY 0.02% 1,065 0% 0% $3,302
SIGNATUREFD, LLC 0.01% 547 0% 0% $1,696
Blue Trust, Inc. 0% 160 0% 0% $496
BANK OF AMERICA CORP /DE/ 0% 117 -15% 0% $363
UBS Group AG 0% 102 -100% 0% $316
Kozak & Associates, Inc. 0% 49 0% 0% $117
FMR LLC 0% 40 0% $124
Global Retirement Partners, LLC 0% 23 0% 0% $71
CITIGROUP INC 0% 1 0% $3
Steward Partners Investment Advisory, LLC 0% 0 -100% $0
CREDIT AGRICOLE S A 0% 0 -100% $0
RAYMOND JAMES FINANCIAL INC 0% 0 -100% $0

Institutional Holders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 49 $101 $2.06 1
2025 Q3 686,727 $2,129,135 +$875,076 $3.10 22
2025 Q2 402,082 $1,271,158 +$424,561 $3.16 18
2025 Q1 281,633 $802,423 -$1,021,559 $2.85 19
2024 Q4 466,818 $2,003,111 +$1,082,495 $4.29 19
2024 Q3 245,048 $630,697 +$156,011 $2.61 22
2024 Q2 186,896 $433,846 -$444,090 $2.22 18
2024 Q1 133,960 $646,578 -$323,172 $4.83 13
2023 Q4 250,540 $3,116,718 +$3,115,885 $12.44 12